Paxlyte Capsule
Product Images NDC 64661-217

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Paxlyte (NDC 64661-217). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Jaymac Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Image Description (Paxlyte Label V7 Cropped (july 24 2024))

Image Description (Paxlyte Label V7 Cropped (july 24 2024))
Paxlyte is a prescription vitamin designed for therapeutic use in patients under the specific direction and monitoring of a physician to address deficiencies in folate and vitamin B, particularly in those with genetic polymorphisms affecting homocysteine metabolism. It contains various active ingredients and cofactors to help lower homocysteine levels, with a specific focus on patients with certain gene polymorphisms. The product information includes details on ingredients, dosage and administration, potential side effects, precautions, indications, and mechanism of action. It is emphasized that Paxlyte requires medical supervision due to the risk of masking vitamin B12 deficiency and potential side effects. The text also includes information about how the product is supplied, storage instructions, and manufacturer details.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.